Market Overview The tumor NGS detection market is expanding rapidly as cancer genomics technology matures and molecular diagnostic innovation accelerates. The Tumor NGS Detection Market is projected to exceed USD 10.5 billion through 2035, driven by genomic medicine adoption, technology cost reduction, and clinical evidence accumulation. Tumor NGS detection market enable molecular diagnosis...